ABCB1 and lymphoid neoplasm: We revealed that this drug also had antitumor effects in canine lymphoid tumor cells and decreased ABCB1 gene expression through activation of the JNK pathway, leading to a reduction of IC50 values for vincristine in a canine lymphoma cell line [98].